Surprisingly, the AUC value of B2M expression in predicting CL and ME subtypes were 91.4% and 90.7% in pan-gliomas and LGGs, respectively, indicating that B2M effectively predicted the more aggressive subtypes. This evidence concerns the gene B2M and glioma.